Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN110551035A details high-efficiency iridium catalysis for chiral amines. Offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN120136859A reveals a novel binaphthyl ligand for synthesizing high-purity seven-membered nitrogen heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN107011218A enables high ee value synthesis of chiral amines reducing steps and improving supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.
Patent CN107011218A details copper catalyzed asymmetric amination enabling efficient synthesis of chiral amines with improved supply chain reliability and cost effectiveness for global buyers
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.